ArticleFrontiers in immunology2017

Development of Novel Promiscuous Anti-Chemokine Peptibodies for Treating Autoimmunity and Inflammation.

Michal Abraham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.